Leveraging its networks in academia, biotech, venture capital and the pharmaceutical industry, Catalys Pacific has assembled a group of Strategic and Preferred Partners with whom to create asset-centric global bioventure companies.
Catalys Pacific begins operations as one of Japanʼs largest life sciences-focused investment firms. The firmʼs mission is to provide solutions to unmet medical needs for patients worldwide by creating and investing in companies that drive innovation in life sciences. Catalys Pacific maintains a strictly independent governance structure that ensures autonomous assessment and decision-making of its investments.
Company Details
- Employees
- 11
- Address
- 8-14, Minami-Aoyama 3-Chome, Auspice Omotesando 4f,japan
- in****@****fic.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- catalyspacific.com
- HQ
- Minato-ku, Tokyo
Catalys Pacific Questions
Catalys Pacific's website is catalyspacific.com
Catalys Pacific's LinkedIn profile is https://jp.linkedin.com/company/catalys-pacific
Catalys Pacific has
11 employees.
View email and phone details for 11
employees at Catalys Pacific.
Catalys Pacific's industry is
Venture Capital and Private Equity Principals
Catalys Pacific's top competitors are
Sr One Capital Management,
Seventure Partners,
Pathalys Pharma,
Jupiter Therapeutics,
Fast Track Initiative,
Davita Venture Group,
Kirilys Therapeutics,
Orbimed,
Defta Partners,
Lupus Research Alliance.
Catalys Pacific's support email address is info@catalyspacific.com
Catalys Pacific's categories are Venture Capital and Private Equity Principals
